BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36303034)

  • 1. Mechanism and modeling of human disease-associated near-exon intronic variants that perturb RNA splicing.
    Chiang HL; Chen YT; Su JY; Lin HN; Yu CA; Hung YJ; Wang YL; Huang YT; Lin CL
    Nat Struct Mol Biol; 2022 Nov; 29(11):1043-1055. PubMed ID: 36303034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.
    Joynt AT; Evans TA; Pellicore MJ; Davis-Marcisak EF; Aksit MA; Eastman AC; Patel SU; Paul KC; Osorio DL; Bowling AD; Cotton CU; Raraigh KS; West NE; Merlo CA; Cutting GR; Sharma N
    PLoS Genet; 2020 Oct; 16(10):e1009100. PubMed ID: 33085659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic analysis of intronic sequences downstream of 5' splice sites reveals a widespread role for U-rich motifs and TIA1/TIAL1 proteins in alternative splicing regulation.
    Aznarez I; Barash Y; Shai O; He D; Zielenski J; Tsui LC; Parkinson J; Frey BJ; Rommens JM; Blencowe BJ
    Genome Res; 2008 Aug; 18(8):1247-58. PubMed ID: 18456862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
    Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
    PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ANO5 intronic Roma variant alters splicing causing muscular dystrophy.
    Mavillard F; Servián-Morilla E; Rivas E; Paradas C; Cabrera-Serrano M
    Clin Genet; 2021 Jul; 100(1):106-110. PubMed ID: 33818761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining genetic constraint with predictions of alternative splicing to prioritize deleterious splicing in rare disease studies.
    Cormier MJ; Pedersen BS; Bayrak-Toydemir P; Quinlan AR
    BMC Bioinformatics; 2022 Nov; 23(1):482. PubMed ID: 36376793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of splice defects due to noncanonical splice site or deep-intronic variants in ABCA4.
    Fadaie Z; Khan M; Del Pozo-Valero M; Cornelis SS; Ayuso C; Cremers FPM; Roosing S; The Abca Study Group
    Hum Mutat; 2019 Dec; 40(12):2365-2376. PubMed ID: 31397521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minigene Splicing Assays and Long-Read Sequencing to Unravel Pathogenic Deep-Intronic Variants in
    Tamayo A; Núñez-Moreno G; Ruiz C; Plaisancie J; Damian A; Moya J; Chassaing N; Calvas P; Ayuso C; Minguez P; Corton M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SpliceAPP: an interactive web server to predict splicing errors arising from human mutations.
    Huang AC; Su JY; Hung YJ; Chiang HL; Chen YT; Huang YT; Yu CA; Lin HN; Lin CL
    BMC Genomics; 2024 Jun; 25(1):600. PubMed ID: 38877417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.
    Wappenschmidt B; Becker AA; Hauke J; Weber U; Engert S; Köhler J; Kast K; Arnold N; Rhiem K; Hahnen E; Meindl A; Schmutzler RK
    PLoS One; 2012; 7(12):e50800. PubMed ID: 23239986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
    Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
    Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing.
    Leman R; Parfait B; Vidaud D; Girodon E; Pacot L; Le Gac G; Ka C; Ferec C; Fichou Y; Quesnelle C; Aucouturier C; Muller E; Vaur D; Castera L; Boulouard F; Ricou A; Tubeuf H; Soukarieh O; Gaildrat P; Riant F; Guillaud-Bataille M; Caputo SM; Caux-Moncoutier V; Boutry-Kryza N; Bonnet-Dorion F; Schultz I; Rossing M; Quenez O; Goldenberg L; Harter V; Parsons MT; Spurdle AB; Frébourg T; Martins A; Houdayer C; Krieger S
    Hum Mutat; 2022 Dec; 43(12):2308-2323. PubMed ID: 36273432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic features defining exonic variants that modulate splicing.
    Woolfe A; Mullikin JC; Elnitski L
    Genome Biol; 2010; 11(2):R20. PubMed ID: 20158892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hotspot exons are common targets of splicing perturbations.
    Glidden DT; Buerer JL; Saueressig CF; Fairbrother WG
    Nat Commun; 2021 May; 12(1):2756. PubMed ID: 33980843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs.
    Vreeswijk MP; Kraan JN; van der Klift HM; Vink GR; Cornelisse CJ; Wijnen JT; Bakker E; van Asperen CJ; Devilee P
    Hum Mutat; 2009 Jan; 30(1):107-14. PubMed ID: 18693280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benchmarking splice variant prediction algorithms using massively parallel splicing assays.
    Smith C; Kitzman JO
    Genome Biol; 2023 Dec; 24(1):294. PubMed ID: 38129864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why Selection Might Be Stronger When Populations Are Small: Intron Size and Density Predict within and between-Species Usage of Exonic Splice Associated cis-Motifs.
    Wu X; Hurst LD
    Mol Biol Evol; 2015 Jul; 32(7):1847-61. PubMed ID: 25771198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
    Petersen USS; Doktor TK; Andresen BS
    Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of
    Weisschuh N; Mazzola P; Bertrand M; Haack TB; Wissinger B; Kohl S; Stingl K
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unpredicted Aberrant Splicing Products Identified in Postmortem Sudden Cardiac Death Samples.
    Coll M; Fernandez-Falgueras A; Iglesias A; Del Olmo B; Nogue-Navarro L; Simon A; Perez Serra A; Puigmule M; Lopez L; Pico F; Corona M; Vallverdu-Prats M; Tiron C; Campuzano O; Castella J; Brugada R; Alcalde M
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.